Merck blueprints $1.3B research hub in a post-Brexit London, with 950 staffers
While the EMA is exiting London over the next 18 months, US pharma giant Merck plans to help fill the post-Brexit gap with a new drug research hub and headquarters with 950 staffers.
Merck has begun to seek a site for its new research center in London, which will be established as Merck concentrates its US forces in Cambridge/Boston and the Bay Area.
Kenilworth, NJ-based Merck is willing to invest about $1.3 billion in the new center, with plans to recruit 150 top scientists for the new hub operation. And City A.M. reports that Merck will relocate staff currently at a facility in Hoddesdon, Hertfordshire. The move is being timed to coordinate with the release of the government’s Industrial Strategy White Paper.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.